1. BMI1 regulates PRC1 architecture and activity through homo- and hetero-oligomerization
   Felicia Gray et al, 2016, Nature Communications CrossRef
2. Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer
   Anne Benard et al, 2014, PLoS ONE CrossRef
3. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
   Hwa-Yong Lee et al, 2020, Cancers CrossRef
4. Encapsulating Epigallocatechin-3-Gallate (EGCG) in Chitosan Nanoparticles Influenced Multiple Genes Controlling Oncostatic Signaling Pathways in HepG2 Cells
   Sameh M. Shabana et al, 2024, Revista Brasileira de Farmacognosia CrossRef
5. A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma
   Taicheng Zhou et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
6. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma
   Kaori Tanaka et al, 2015, Oncotarget CrossRef
7. Association between RNF2+P‑AKT expression in pretreatment biopsy specimens, and poor survival following radiotherapy in patients with esophageal squamous cell carcinoma
   Qiaofang Li et al, 2019, Oncology Letters CrossRef
8. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma
   Ru Wang et al, 2022, Technology in Cancer Research & Treatment CrossRef
9. Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma
   Monica Bartucci et al, 2017, Targeted Oncology CrossRef
10. Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice
    Shibo Qi et al, 2014, International Journal of Molecular Sciences CrossRef